期刊文献+

左心室射血分数保留的老年心力衰竭病人心率变异性与血浆氨基末端脑钠肽前体的相关性分析 被引量:24

Correlation analysis of heart rate variability and N-terminal probrain natriuretic peptide precursor in elderly patients with heart failure with left ventricular ejection fraction
下载PDF
导出
摘要 目的探讨左心室射血分数保留的老年心力衰竭(HFpEF)病人心率变异性(HRV)与血浆氨基末端脑钠肽前体(NT-proBNP)的相关性,为HFpEF的诊断提供参考指标。方法选取阆中市人民医院2014年1月至2017年5月住院的98例慢性心功能衰竭(CHF)老年病人为心衰组,男性54例,女性44例,年龄(70.0±6.3)岁;根据美国纽约心脏协会(NYHA)心功能分级分为心功能Ⅱ级组、心功能Ⅲ级组、心功能Ⅳ级组。选择同期住院的41例无CHF老年病人为对照组,男性22例女性19例,年龄(71.5±4.4)岁。完善NT-proBNP及动态心电图等相关检查。结果心衰组的尿酸(385.5±93.4)mmol/L、NT-proBNP(2 294.9±626.2)高于对照组(308.4±89.5)mmol/L、(196.2±59.9),差异有统计学意义(P<0.05);心衰组的正常RR间期标准差(SDNN)[(88.9±15.0)比(140.4±17.9)]、5 min均值标准差(SDANN)[(77.2±13.6)比(127.5±12.7)]、全程相邻RR间期之差的平方根(RMSSD)[(21.6±4.6)比(36.6±10.2)]、相邻RR间期相差>50 ms的个数占总心跳数的百分比(PNN50)[(6.4±2.3)比(17.5±6.2)]低于对照组,差异有统计学意义(P<0.05);随着心功能减退,SDNN、SDANN、RMSSD、PNN50逐渐降低,NT-proBNP逐渐升高。NT-proBNP与SDNN、SDANN、RMSSD、PNN50呈负相关(r=-0.854,P<0.01;r=-0.876,P<0.01;r=-0.737,P<0.01;r=-0.698,P<0.01)。结论 NT-proBNP与HRV的相关指标均能反映心力衰竭,随着心力衰竭加重NT-proBNP逐渐增高,而HRV的相关指标逐渐降低,NT-proBNP与HRV的相关指标呈负相关。 Objective To investigate the correlation between heart rate variability(HRV)and plasma N-terminal probrain natriuretic peptide(NT-proBNP)in elderly heart failure with left ventricular ejection fraction preserved(HFpEF),and to provide reference for the diagnosis of HFpEF.Methods A total of 98 chronic heart failure(CHF)elderly patients who were hospitalized in Langzhong People’s Hospital from January 2014 to May 2017 were selected as CHF group,there were 54 male and 44 female patients,the average age of the patients was(70.0±6.3)years.According to the American Heart Association New York heart function NYHA grade,they were assigned into three groups including group Ⅱ of cardiac function,group III of cardiac function,group Ⅳ of cardiac function.41 cases of heart failure in elderly patients without CHF hospitalized during the same period were selected as control group,there were 22 male and 19 female patients,the average age was(71.5±4.4)years.All people should do NT-proBNP and dynamic electrocardiogram examination.Results The uric acid[(385.5±93.4)mmol/L vs.(308.4±89.5)mmol/L],NT-proBNP[(2 294.9±626.2)vs.(196.2±59.9)]in CHF group were higher than those in the control group,and the difference was statistically significant(P<0.05).SDNN[(88.9±15.0)vs.(140.4±17.9)],SDANN[(77.2±13.6)vs.(127.5±12.7)],RMSSD[(21.6±4.6)vs.(36.6±10.2)]and PNN50[(6.4±2.3)vs.(17.5±6.2)]in CHF group were lower than those in the control group,and the difference was statistically significant(P<0.05).With the decrease of cardiac function,SDNN,SDANN,RMSSD and PNN50 gradually decreased,while NT-proBNP gradually increased.Nt-probnp was negatively correlated with SDNN,SDANN,RMSSD and PNN50(r=-0.854,P<0.01;r=0.876,P<0.01;r=0.737,P<0.01;r=-0.698,P<0.01).Conclusion The related indicators of NT-proBNP and HRV can reflect heart failure.With the increase of the heart failure,NT-proBNP gradually increases,while the relevant indicators of HRV gradually decrease,and the related indicators of NT-proBNP and HRV are negatively correlated.
作者 许波 蒲世军 蒲国俭 杨军 沈媚嘉 蒲阳 XU Bo;PU Shijun;PU Guojian;YANG Jun;SHEN Meijia;PU Yang(Department of Cardiology,Langzhong People’s Hospital,Nanchong,Sichuan 637000,China)
出处 《安徽医药》 CAS 2020年第2期327-330,共4页 Anhui Medical and Pharmaceutical Journal
关键词 心力衰竭 利钠肽 心率 尿酸 心脏功能试验 心电描记术 便携式 老年人 氨基末端脑钠肽前体(NT-proBNP) 心率变异性 Heart failure Natriuretic peptide,brain Heart rate Uric acid Heart function tests Electrocardiography,ambulatory Aged N-terminal probrain natriuretic peptide(NT-proBNP) Heart rate variability
  • 相关文献

参考文献2

二级参考文献16

  • 1Gregg C. Fonarow,William F. Peacock,Tamara B. Horwich,Christopher O. Phillips,Michael M. Givertz,Margarita Lopatin,Janet Wynne.Usefulness of B-Type Natriuretic Peptide and Cardiac Troponin Levels to Predict In-Hospital Mortality from ADHERE[J]. The American Journal of Cardiology . 2008 (2)
  • 2Clyde W. Yancy,Mariell Jessup,Biykem Bozkurt,Javed Butler,Donald E. Casey,Mark H. Drazner,Gregg C. Fonarow,Stephen A. Geraci,Tamara Horwich,James L. Januzzi,Maryl R. Johnson,Edward K. Kasper,Wayne C. Levy,Frederick A. Masoudi,Patrick E. McBride,John J.V. McMurray,Judith E. Mitchell,Pamela N. Peterson,Barbara Riegel,Flora Sam,Lynne W. Stevenson,W.H. Wilson Tang,Emily J. Tsai,Bruce L. Wilkoff.2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. Circulation . 2013 (16)
  • 3Yaron Goren,Michal Kushnir,Barak Zafrir.Serum levels of microRNAs in patients with heart failure. EUROPEAN JOURNAL OF HEART FAILURE . 2012
  • 4McMurray John J V,Adamopoulos Stamatis,Anker Stefan D,Auricchio Angelo,B?hm Michael,Dickstein Kenneth,Falk Volkmar,Filippatos Gerasimos,Fonseca Candida,Gomez-Sanchez Miguel Angel,Jaarsma Tiny,K?ber Lars,Lip Gregory Y H,Maggioni Aldo Pietro,P.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart. European journal of heart failure . 2012
  • 5Macdonald JE,Kennedy N,Struthers AD.Effects of spironolactone on endothelial function , vascular angiotensin converting enzyme activity , and other prognostic markers in patients with mild heart failure already taking optimal treatment. Heart . 2004
  • 6Bahrmann P,Bahrmann A,Hofner B,et al.Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department. Eur Heart J Acute Cardiovasc Care . 2015
  • 7Rongcheng Zhang,Yuhui Zhang,Tao An,Xiao Guo,Shijie Yin,Yunhong Wang,James L Januzzi,Thomas P Cappola,Jian Zhang.??Prognostic value of sST2 and galectin-3 for death relative to renal function in patients hospitalized for heart failure(J)Biomark. Med. . 2015 (5)
  • 8Tijsen AJ,Creemers EE,Moerland PD, et al.MiR423-5p as a circulating biomarker for heartfailure. Circulation Research . 2010
  • 9Porapakkham P.,Porapakkham P.,Zimmet H.,Billah B.,Krum H.B-type natriuretic peptide-guided heart failure therapy: A meta-analysis. Archives of Internal Medicine . 2010
  • 10Peacock W Frank,De Marco Teresa,Fonarow Gregg C,Diercks Deborah,Wynne Janet,Apple Fred S,Wu Alan H B.Cardiac troponin and outcome in acute heart failure. The New England Quarterly . 2008

共引文献20

同被引文献250

引证文献24

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部